skip to main content

Chronic Neurological Disease

Faculty

Beth Boudreau

Boudreau’s research focuses on neuroinflammation, neuro-oncology, and non-invasive prognostic indicators for neurological disease.

Dr. Boudreau

C. Jane Welsh

The long-term goal of Dr. Welsh’s research is to understand how viral infections instigate the pathogenesis of neurological and autoimmune conditions. To this end, her laboratory has investigated the Theiler’s virus-induced demyelination (TVID) model of multiple sclerosis (MS) and epilepsy.

Dr. Welsh

Ashok K. Shetty

Shetty’s laboratory is interested in developing clinically applicable strategies that are efficacious for enhancing brain function after injury, disease, or aging.

Dr. Shetty's Lab

D. Samba Reddy

The Reddy lab is developing innovative, disease-modifying therapies for preventing the development and progression of epilepsy.

Reddy Lab

Xin Wu

Wu’s recent research in cardiovascular and neuronal systems focuses on: 1) which ion channels are activated by mechanical stress, 2) which ion channels are modulated by integrins, 3) how integrin-mediated signaling pathways modulate ion channel function and mechanotransduction in physiological and pathological conditions, 4) epilepsy study, neurosteroids and new drug development.

Xin Wu

Roderick H. Dashwood

The Dashwood Lab examines genetic and epigenetic changes in cancer. Lab members come from diverse research backgrounds including molecular toxicology, biochemistry, cell biology, genetics, pharmacology, pharmacy, and nutrition.

Dashwood Lab

Praveen Rajendran

Rajendran’s research relates to identifying novel epigenetic approaches to the treatment and prevention of colorectal cancer, where most therapeutic options are woefully ineffective.

Dr. Rajendran

Robert Tsai

Tsai laboratory is currently focused on developing and commercializing a novel 3-D-printed mucoadhesive patch to eradicate oral precancerous lesions; creating new diagnostic models to predict the risk of liver and oral precancerous lesions in developing into cancers; and determining the efficacy of a new class of nanomedicine in treating glioblastoma multiforme using orthotopic mouse brain tumor models.

Tsai Lab

Thomas A. Kent

Kent’s research program focuses on development of new therapeutic approaches using nanomedicine to treat brain injury in stroke, dementia and mitochondrial disorders.

Dr. Kent

Kent Lab

Rahul Srinivasan

Dr. Srinivasan’s research focuses on developing a mechanistic understanding of neurodegeneration, with the goal of discovering novel strategies to treat neurodegenerative disorders

Dr. Srinivasan

Mendell Rimer

Research in the Rimer lab centers on the molecular and cellular mechanisms underlying the formation, maintenance and pathology of synapses, the connections between nerve cells and their targets.

Dr. Rimer

David J. Earnest

Research in Dr. Earnest’s laboratory employs multidisciplinary approaches to study the cellular and molecular neurobiology of cell-autonomous circadian clocks and the signal transduction pathway responsible for circadian photoentrainment.

Dr. Earnest

Vishal Gohil

The research in Dr. Gohil’s laboratory is focused on the discovery and characterization of genes required for building the mitochondrial energy generating machinery.

Gohil Lab

Dr. Gohil

Shameena Bake

Dr. Bake is primarily interested in stroke research. Current studies use an animal model to examine age and sex differences in recovery from stroke, focusing at the cellular level and astrocytes, and impact of alcohol consumption on stroke outcomes.

Ian Murray

Dr. Murray has been engaged in lipid and neurodegenerative disease research
for the past 30 years in both academic and industrial settings. He carried out
seminal studies in the field of protein folding involved in obesity, Parkinson's,
and Alzheimer's diseases.

Dr. Murray

Alex Keene

Dr. Keene and his team are interested in the neural regulation of sleep, appetite, and energy homeostasis and the regulation of sleep-metabolism interactions.

Dr. Keene

Keene Lab

Karen Newell-Rogers

Dr. Newell and her team study how individual molecular immune responses contribute to the manifestation of infectious and post-infectious chronic
inflammatory syndromes, and how a cell's energy demands, and energy strategy impact the ability of the cell to be recognized by the immune system.

Dr. Newell

Lee Shapiro

Dr. Shapiro’s lab focuses on neuroanatomical, neuropathological, neuroimmune and peripheral contributions to neurodegenerative disorders, traumatic brain injury and epilepsy.

Dr. Shapiro

Irtisha Singh

Dr. Singh’s team studies the pathophysiology of glioblastoma multiforme with the goal to understand dysregulation of transcriptional and co-transcriptional regulatory programs as drivers of malignancies and is interested in epigenetic and transcriptional regulatory programs.

Dr. Singh

Singh Lab

Ursula H. Winzer-Serhan

Dr. Winzer-Serhan’s lab is interested in nicotinic receptor functions in brain development, addiction and epilepsy, and interactions with the immune system.

Dr. Winzer-Serhan

Hua Zhang

Dr. Zhang is interested in the Roles of bone morphogenetic protein 1 (BMP1)/tolloid-like I (TLL1) proteinases in dentinogenesis and the roles of FAM20C (family with sequence similarity 20, member C) and SIBLING (small integrin binding ligands N-linked glycoprotein) family proteins in brain homeostasis.

Dr. Zhang

Dr. Gerard Toussaint

Dr. Toussaint